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Background and purpose of the study: Recent studies demonstrate that androgens, beyond regulating sexual
behavior, exert several neuroprotective functions in the brain. The present study was designed to explore effect of
testosterone in memory impairment induced by intra- cerebroventricular (icv) injection of streptozotocin (STZ) as a
model of sporadic AD.
Methods: Study was carried out on male Wistar rats. Animals were randomly divided into 11 equal groups.
Experimental model of AD was induced by bilateral icv injection of STZ at the dose of 750 μg/Rat/10 μl ACSF at
days 1 and 3. STZ-induced memory impairment was assessed two weeks after the last dose of STZ by using a
passive avoidance task (1 mA). The interval between the placement of animals in the illuminated chamber and the
entry into the dark chamber was measured as a step-through latency (STL). Castration was performed by surgical
removing of testis and behavioral study of memory impairment was done after 4 weeks.
Results: Results of this study showed that icv injection of STZ could induce marked (p < 0.05) memory impairment
at the dose of 750 μg/Rat/dissolve10 μl CSF/bilateral/days 1 and 3. Therefore, we used this dose of STZ for
induction of experimental model of AD. Memory was worsened in castrated rats (P < 0.05) when compared with
normal and sham-operated animals. Testosterone replacement therapy (1 mg/kg, sc, for 6 days) in 4 week castrated
rats restored memory up to the level of control groups. Testosterone had not any significant effect on memory
impairments of non-castrated rats.
Major conclusion: According to the obtained results it can be concluded that testosterone improves cognitive and
memory impairment of AD. We suggest that testosterone replacement therapy may have beneficial effect in
ameliorating memory impairments of senile patients suffering from AD. Further clinical studies should be carried
out to prove possible useful effect of testosterone as an adjuvant therapy in AD.
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Alzheimer’s disease is the most common form of
dementia in the elderly. The features of Alzheimer’s dis-
ease are an amnesic type of memory impairment [1],
deterioration of language [2] and visuospatial deficits
[3] Motor and sensory abnormalities, gait disturbances,
and seizures are uncommon until the late phases of the
disease [4]. There is increasing consensus that the* Correspondence: nayebia@tbzmed.ac.ir
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distribution, and reproduction in any mediumproduction and accumulation of beta-amyloid (Aβ)
peptide is central to the pathogenesis of Alzheimer’s
disease [5]. Cerebral plaques laden with Aβ and dystrophic
neuritis in neocortical terminal fields as well as prominent
neurofibrillary tangles in medial temporal-lobe structures
are important pathological features of Loss of neurons
and white matter, congophilic (amyloid) angiopathy,
inflammation, and oxidative damage are also present
Alzheimer’s disease [3].
The brain is a well recognized target tissue for andro-
gens [1]. Testosterone (T) acts on neurons and glial cells
within multiple sex-hormone sensitive brain areastral Ltd. This is an Open Access article distributed under the terms of the
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and indirect pathway following aromatization [6]. Regu-
lation of AR protein and AR mRNA by androgens has
been observed in mammals in multiple androgen-
responsive tissues, such as brain [7]. One of the less
known testosterone actions is neuroprotection [8]. In
the brain, ARs are expressed by both neurons and glial
cells and are mainly found in the thalamus, hypothal-
amus, hippocampus, amygdale and cerebral cortex
where they often co-localize with estrogen receptors
(ERs) [9]. During adolescence, T is involved in the acti-
vation of preformed brain structures leading to sexually
dimorphic physical behavioral and cognitive effects. In
adulthood, T exerts neuromodulatory functions that
contribute to maintain brain structural and functional
homeostasis [1].
T deficiency may be important in patients with
Parkinson disease (PD) [10] and Alzheimer disease [11].
It is not well known,however, whether replacement of
testosterone in men with borderline hypogonadism and
neurodegenerative diseases is of substantial benefit.
Androgens significantly modulate specific aspects of
cognition, and that androgen depletion, either through
normal aging or pharmacological action can result in
specific cognitive impairments, increased incidence of
neurodegenerative diseases and worse prognosis after
brain injury [12]. Brain levels of T were significantly
depleted in men with severe AD, indicating that T loss
likely precedes development of AD [13]. Clinical studies
investigating the effects of testosterone replacement
therapy on the cognitive behaviors of healthy older men
have produced mixed results, with some studies showing
improved spatial ability in men receiving testosterone
[14,15], while other studies have shown no effect of tes-
tosterone on cognition [14,16]. The results of animal
studies are also inconsistent. In various versions of the
radial arm maze and T-maze, castration has been shown
to impair spatial memory [17,18], whereas other study
showed that testosterone replacement in castrated male
rats did not restore spatial memory performance on the
radial arm maze [19]. These contradictory results high-
light the need for the use of rodent models of AD to test
the effect of testosterone on memory performance upon
other behavioral tests. Therefore, this study designed to
investigate role of testosterone in memory impairment
induced by streptozotocin (STZ) as a model of sporadic
AD by using of passive avoidance test.
Material and methods
Chemicals
All chemicals were obtained from sigma except for tes-
tosterone enanthate which was purchased from Daroo
pakhsh (Tehran, Iran). Solutions were prepared freshly
on the days of experimentation.Testosterone and STZ were dissolved in sterile castor
oil and artificial CSF (ACSF: 120 mM NaCl; 3 mM KCl;
1.15 mM CaCl2; 0.8 mM MgCl2; 27 mM NaHCO3; and
0.33 mM NaH2PO4 adjusted to pH 7.2) respectively.
Animals
The study was performed on male Wistar rats weighting
220–250 g. Animals were housed in standard polypro-
pylene cages, four per cage, under 12:12-h L/D program
and at an ambient temperature of 25±2°C, with free ac-
cess to food and water. Experiments were carried out
under the ethical guidelines of the Tabriz University of
Medical Sciences for the care and use of laboratory
animals.
Castration
Animals were anesthetized by intraperitoneal (ip) injec-
tion of ketamine (60 mg/kg) and xylazine (6 mg kg). The
ventral scrotum was shaved and scrubbed with betadine
(Behvazan Co, Rasht, Iran). Then 1.5 cm transverse inci-
sion was made at midline scrotum; the testes were exter-
iorized through the incision; the tubules were tied with
0.4 silk suture; and finally testes and testicular fat were
removed. The sham surgery consisted of exposing the
gonads without removing them. Behavioral studies were
done 4 weeks after castration.
Intracerebroventricular (icv) injection of STZ
Animals were anesthetized with a combination of keta-
min (60 mg/kg, ip) and xylazine (6 mg/kg, ip). After they
were deeply anesthetized, rats were mounted in a stereo-
taxic frame in the flat skull position. The scalp was
shaved and swabbed with iodine and a small central inci-
sion was made to expose the skull. Then two bilateral
burr hole were drilled through the skull with the coordi-
nates according to the stereotaxic atlas [20]: anteropos-
terior from bregma (AP) = −0.8 mm, mediolateral from
the midline (ML) = ±1.6 mm and dorsoventral from the
skull (DV) = 3.4 mm. STZ (750 μg/10 μl ACSF/Rat, at
days 1 and 3) was infused bilaterally into the cerebral
ventricles by using a Hamilton syringe and an infusion
pump at a flow rate of 0.2 μl/min [19]. Behavioral inves-
tigations were carried out 2 weeks after the first injec-
tion of STZ.
Passive avoidance test
The apparatus (Azma Co., Tabriz) consisted of an illumi-
nated chamber connected to dark chamber by a guillotine
door. Electric shocks were delivered to the grid floor by an
stimulator. On the first and second days of testing, each
rat was placed on the apparatus and left for 5 min to ha-
bituate to the apparatus. On the third day, an acquisition
trial was performed. Rats were individually placed in the
illuminated chamber. After a habituation period (2 min),
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ing the dark chamber, the door was closed and an in-
escapable scrambled electric shock (1 mA, 50HZ, 3 s
once) was delivered. In this trial, the initial latency (IL)
of entrance into the dark chamber was recorded and
rats with IL greater than 60 s were excluded from the
study. Twenty-four hours later, each rat was placed in
the illuminated chamber for retention trial. The interval
between the placement in the illuminated chamber and
the entry into the dark chamber was measured as step-
through latency (STL1, Cut of time 900 s) for short
memory. This test was conducted after 3 weeks post-
surgery and each rat was tested only once for measured
STL2 for long memory.
Statistical analyses
Descriptive staticises and comparisons of differences be-
tween means of data sets were calculated by using In-
state software. All results were expressed as the mean ±
SEM and were analyzed one-way ANOVA. Statistical
significance was accepted at the level of P < 0.05. In the
case of significant variation (p < 0.05), the values were
compared using post-hoc Tukey’s test.
Results
The effect of STZ on memory impairments
The Step through latency (STL) was assessed in intact,
STZ (750 μg/10 μl ACSF/Rat, at days 1 and 3) and STZ
vehicle-treated rats. As it has been shown in Figure 1, the
STL1 and STL2 were decreased significantly (P < 0.001)
when compared with intact and STZ vehicle-treated
animals.
The effect of castration on STZ induced-memory
impairments
The STL was assessed in intact, STZ (750 μg/10 μl ACSF/
Rat, at days 1 and 3)-treated, Castrated and STZ-treated
and castrated animals. As it has been shown in Figure 2,
the STL1 and STL2 of STZ, Castration + STZ and
castrated groups were decreased significantly (P < 0.001)
when compared with intact and STZ vehicle-treated
animals.Figure 1 STl1 (short memory) and STL2 (long memory) in intact, STZ-
± SEM of STL (s); n = 8 rats for each group; ***p < 0.001 when compared wThe effect of testosterone replacement on STZ induced-
memory impairments
Seven groups of rats were shedoulded as: 1) normal rats;
2) testosterone (1 mg/kg, sc, for 6 days)-treated rats; 3)
STZ –treated rats; 4) STZ and testosterone (1 mg/kg, sc,
for 6 days)-treated rats; 5) STZ-treated and castrated
rats; 6) testosterone replacement in STZ-treated and
castrated animals; 7) STZ-treated and castrated animals
which were treated with vehicle of testosterone.
The STL1 and STL2 of testosterone-treated rats were
same as the normal animals. In STZ-treated rats which
were treated with testosterone, the STL1 and STL2 were
significantly (P < 0.001) higher than STZ-treated animals.
Furthermore, the amount of STL1 and STL2 were
increased significantly (P < 0.01) by testosterone replace-
ment therapy of STZ-treated and castrated rats when
compared with also STL was assessed of Testosterone in
STZ + Castration with testosterone replacement group
was STZ + castration group (Figure 3).
Discussion
The present study demonstrated that STZ (750 μg/10 μl
ACSF/Rat, at days 1 and 3) decreased short (STL1) and
long (STL2) memory significantly relative to intact and
STZ vehicle-treated. In other words it could cause mem-
ory impairment as a symptom of AD. This is in accord-
ance with other reports showed that ICV injection of
STZ could induce an experimental model of sporadic
AD [21]. This dose of STZ is safe and has been shown
do not cause any change in the peripheral blood glucose
level [22]. Thus, this protocol was used throughout this
study to create animal model of sporadic AD. According
to the previous studies, it is known that the effect of
testosterone on STZ-induced memory impairment in
passive avoidance task has not been studied clearly.
Therefore, we used 4-week castrated rats to investigate
effect of testosterone depletion on STZ-induced memory
impairment. Our results showed that in 4-week castrated
rats which were treated with STZ there was a marked
memory impairment when assessed by passive avoidance
test. This confirms the results of previous study showing
that testosterone can have positive activation effects ontreated and STZ vehicle-treated rats. Each bar represents the mean
ith intact and STZ vehicle-treated groups.
Figure 2 STl1 (short memory) and STL2 (long memory) in intact, STZ-treated, STZ + Castration and Castration treated rats. Each bar
represents the mean ± SEM of STL (s); n = 8 rats for each group; ***p < 0.001 when compared with intact group.
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that plasma concentration of testosterone decreases sig-
nificantly to the undetectable level in 2-week castrated
rats [24]. Thus, we can assume that castration-induced
memory impairments are related to decrease of serum
testosterone levels. Studies indicate that aromatization of
androgens to estrogens is a requisite step in some of
central action of sex steroids in males of several mam-
malian species [25]. Estradiol implants were shown to
improve spatial memory in castrated rats [26]. Similarly,
intra-hipocampal injections of estradiol enhanced the
performance of male rats in Morris water maze [27].
Thus the role of this metabolic pathway in memory im-
proving effect of testosterone is not negligible.
Castration-induced memory impairment may be caused
indirectly by dysregulation of the hypothalamic-pituitary-
gonadal axis. Testosterone normally has negative feedback
effects on the brain that keeps levels of gonadotropins































Figure 3 STl1 (short memory) and STL2 (long memory) in normal, Tes
STZ + Castration + Testosterone and STZ + castration + Vehicle- treat
each group; ***p < 0.001 when compared with STZ -treated group; **p < 0regulation of luteinizing hormone (LH) and follicle stimu-
lating hormone (FSH) [28]. Some recent studies have
shown that elevated LH impairs spatial memory in female
rats [29], and therefore elevated LH may have similar
effects in castrated male rats.
In this study testosterone had not any significant
effects on STL1 and STL2 of normal non-castrated rats.
Thus, it may be assumed that increase of testosterone
level to more than physiological amount has not improv-
ing effect on memory of normal non-castrated animals.
Although testosterone improved markedly short and
long term memory of STZ-treated rats and castrated rats
which were treated with STZ, but it was not able to re-
store memory up to the level of normal animals. This
could be due to inadequate doses of testosterone.
According to the results, we conclude that castration
after 4 weeks diminishes memory in STZ-treated rats, while
testosterone replacement therapy attenuates castration-




































tosterone, STZ -treated, STZ + Testosterone, STZ + Castration,
ed rats. Each bar represents the mean ± SEM of STL (s); n = 8 rats for
.01 when compared with STZ + Castration-treated group.
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tinely used anti-alzheimer drugs to prevent progressive
trends of AD. However, further clinical investigations are
needed to prove this hypothesis.
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